The FDA just issued a warning on RU-486—the drug used to cause medical abortions—after two women died from secondary infections after taking the pill
to end their pregnancies. But the FDA waited until about 27,000 people had died from heart attacks and strokes while taking arthritis drug Vioxx
before pulling that drug. Why the discrepancy?
The death of one woman last January prompted the FDA to issue a warning notice on the so-called abortion pill, RU-486. The woman did not die as a
direct cause of the medication, but rather a secondary infection that set in afterward. It was only the second such case reported after using
RU-486.
Compare that FDA response to its handling of Merck’s hot-selling arthritis pill, Vioxx. Warnings on that pill have been flooding in from around the
world for more than two years—warnings the FDA ignored. The pill worked fine at alleviating pain—especially for the estimated 27,000 users it killed.
It seems Vioxx had some nasty side affects: heart attacks and strokes.
Why did the FDA allow Vioxx to stay on the market for two years while the body count associated with its use continued to climb? Could it have
anything to do with the face that Merck, a contributor to the recent Bush re-election campaign, was making approx. $2.5 billion a year from Vioxx
sales? Could the discrepency in its handling of these two cases also have been influenced by the fact that "the company that produces RU-486 is
foreign and therefore not allowed by federal law to contribute to American campaigns. The Bush campaign and the GOP has not, and never will, get a
dime from RU-486 sales"?
The FDA’s warning on RU-486 was a "no-cost way of showing the religious right that their vote for Bush was not wasted." As the saying goes, money
talks. It's a shame that its voice is louder than the American people's.
source:
www.tompaine.com...
